Skip to main content
SpringerLink
Log in
Book cover

Multimodal Concepts for Integration of Cytotoxic Drugs pp 197–213Cite as

Applications in Esophageal and Gastric Cancer

  • Chapter

  • 558 Accesses

Part of the Medical Radiology book series (Med Radiol Radiat Oncol)

Keywords

  • Gastric Cancer
  • Esophageal Cancer
  • Clin Oncol
  • Radiat Oncol Biol Phys
  • Esophageal Carcinoma

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (Canada)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Ajani JA, Ota DM, Jessup JM, et al. (1991) Resectable gastric carcinoma. An evaluation of preoperative and postoperative chemotherapy. Cancer 68:1501–1506

    CrossRef  PubMed  CAS  Google Scholar 

  • Ajani JA, Mansfield PF, Janjan N, et al. (2004) Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric adenocarcinoma. J Clin Oncol 22:2774–2780

    CrossRef  PubMed  CAS  Google Scholar 

  • Allal AS, Zwahlen D, Bründler MA, et al. (2005) Neoadjuvant radiochemotherapy for locally advanced gastric cancer: long-term results of a phase I trial. Int J Radiat Oncol Biol Phys 63:1286–1289

    CrossRef  PubMed  Google Scholar 

  • Allum W, Cunningham D, Weeden S on behalf of the NCRI Upper GI Clinical Study Group (2003) Perioperative chemotherapy in operable gastric and lower esophageal cancer. A randomized controlled trial (the MAGIC trial ISRCTN 93793971). Proc Am Soc Clin Oncol 998a

    Google Scholar 

  • Al Sarraf M, Martz K, Herskovic A, et al. (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277–284

    Google Scholar 

  • Ancona E, Ruol A, Santi S, et al. (2001) Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with respectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial or preoperative chemotherapy versus surgery alone. Cancer 91:2165–2174

    CrossRef  PubMed  CAS  Google Scholar 

  • Ando N, Iizuka T, Kakegawa T, et al. (1997) A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. J Thorac Cardiovasc Surg 114:205–209

    CrossRef  PubMed  CAS  Google Scholar 

  • Ando N, Iizuka T, Ide H, et al. (2003) Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study JCOG 9204. J Clin Oncol 21:4592–4596

    CrossRef  PubMed  Google Scholar 

  • Apinop C, Puttisak P, Preecha N (1994) A prospective study of combined therapy in esophageal cancer. Hepatology Gastroenterol 41:391–393

    CAS  Google Scholar 

  • Arnott SJ, Duncan W, Kerr GR, et al. (1992) Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol 24:108–113

    CrossRef  PubMed  CAS  Google Scholar 

  • Baba M, Natsugoe S, Shimada M, et al. (2000) Prospective evaluation of preoperative chemotherapy in respectable squamous cell carcinoma of the thoracic esophagus. Dis Esophagus 13:136–141

    CrossRef  PubMed  CAS  Google Scholar 

  • Badwe RA, Sharma V, Bhansali MS, et al. (1999) The quality of swallowing for patients with operable esophageal carcinoma. Cancer 85:763–768

    CrossRef  PubMed  CAS  Google Scholar 

  • Bareiss D, Stabenow R, Müller R, et al. (2002) Aktuelle Epidemiologie des Ösophaguskarzinoms und des Kardiakarzinoms in Deutschland (German). Dtsch Med Wochenschr 127:1367–1374

    CrossRef  PubMed  CAS  Google Scholar 

  • Bartels H, Stein HJ, Siewert JR (1998) Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Brit J Surg 85:840–844

    CrossRef  PubMed  CAS  Google Scholar 

  • Bedenne L, Michel P, Bouche O, et al. (2002) Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102). Proc Am Soc Clin Oncol No. 519

    Google Scholar 

  • Blazeby LM, Conroy T, Hammerlid E, et al. (2003) Clinical and psychometric validation of an EORTC questionaire module, the EORTC QLQ-OES 18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 39:1384–1394

    CrossRef  PubMed  CAS  Google Scholar 

  • Bosset JF, Gignoux M, Triboulet JP, et al. (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337:161–167

    CrossRef  PubMed  CAS  Google Scholar 

  • Burmeister BH, Smithers BM, Gebski V, et al., Trans Tasman Radiation Oncology Group, Australasian Gastrointestinal Trials Group and Clinical Trials Centre (2005) Surgery alone versus chemoradiotherapy followed by surgery for respectable cancer of the esophagus: a randomised controlled phase III trial. Lancet Oncol 6:659–668

    CrossRef  PubMed  Google Scholar 

  • Chiu PW, Chan AC, Leung SF, et al. (2005) Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 9:794–802

    CrossRef  PubMed  Google Scholar 

  • Daly JM, Karnell LH, Menck HR (1996) National cancer data base report on esophageal carcinoma. Cancer 78:1820–1828

    CrossRef  PubMed  CAS  Google Scholar 

  • ESMO European Society of Medical Oncology Guidelines (2005). www.esmo.org

    Google Scholar 

  • Earle CC, Maroun JA (1999) Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomized trials. Eur J Cancer 35:1059–1064

    CrossRef  PubMed  CAS  Google Scholar 

  • Fiorica F, Di Bona D, Schepis F, et al. (2004) Preoperative chemoradiotherapy for oesophageal cancer: a systemic review and meta-analysis. Gut 53:925–930

    CrossRef  PubMed  CAS  Google Scholar 

  • Fok M, Sham JST, Choy D, et al. (1993) Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 113:138–147

    PubMed  CAS  Google Scholar 

  • Fok M, McShane J, Law SYK, Wong J (1994) Prospective randomized study in the treatment of oesophageal carcinoma. Asian J Surg 17:223–229

    Google Scholar 

  • Gignoux M, Roussel A, Paillot B, et al. (1987) The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg 11:426–432

    CrossRef  PubMed  CAS  Google Scholar 

  • Gunderson LL (2002) Gastric cancer-patterns of relapse after surgical resection. Semin Radiat Oncol 12:150–161

    CrossRef  PubMed  Google Scholar 

  • Hallissey MT, Dunn JA, Ward LC, Allum WH (1994) The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet 343:1309–1312

    CrossRef  PubMed  CAS  Google Scholar 

  • Hartgrink HH, van de Velde CJ, Putter H, et al. (2004) Neoadjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial. Eur J Surg Oncol 30:643–649

    CrossRef  PubMed  CAS  Google Scholar 

  • Hermanek P (1999) Tumor of the gastrointestinal tract and the pancreas: histopathology, staging, and prognosis. Anticancer Res 19:2393–2396

    PubMed  CAS  Google Scholar 

  • Hermans J, Bonenkamp JJ, Boon MC, et al. (1993) Adjuvant therapy after curative resection for gastric cancer: metaanalysis of randomized trials. J Clin Oncol 11:1441–1447

    PubMed  CAS  Google Scholar 

  • Hironaka S, Ohtsu A, Boku N, et al. (2003) Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T (2-3) N (any) M (0) Squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 57:425–433

    CrossRef  PubMed  Google Scholar 

  • Hosch SB, Stoecklein NH, Pichlmeier U, et al. (2001) Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol 19:1970–1975

    PubMed  CAS  Google Scholar 

  • Hundahl SA (2002) Staging, stage migration, and patterns of spread in gastric Cancer. Semin Radiat Oncol 12:141–149

    CrossRef  PubMed  Google Scholar 

  • Janunger KG, Hafstrom L, Glimelius B (2002) Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg 168:597–608

    PubMed  CAS  Google Scholar 

  • Kelsen D, Karpeh M, Schwartz G et al. (1996) Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol 14:1818–1828

    PubMed  CAS  Google Scholar 

  • Kok TC, van Lanschot J, Siersema PD, van Overhagen H, Tilanus HW, for the Rotterdam Esophageal Tumor Study Group (1997) Neoadjuvant chemotherapy in operable esophageal squamous cell cancer: final report of a phase III multicenter randomized controlled trial (abstract). Proc Am Soc Clin Oncol 16:277a, abstract 984

    Google Scholar 

  • Kollmannsberger C, Budach W, Stahl M, et al. (2003) Adjuvant radiochemotherapy using 5-FU/Folinacid/cisplatin +/-paclitaxel and radiation in patients with completely (R0) resected high-risk gastric cancer (UICC stages II-IV (M0): A phase II study of the AIO/ARO/ACO. Onkologie 26 Sonderheft 5:32–34

    Google Scholar 

  • Korst RJ, Altorki NK (2004) Imaging for esophageal tumors. Thorac Surg Clin 14:61–69

    CrossRef  PubMed  Google Scholar 

  • Kosho M, Esiashvillie N, Landry JC, et al. (2004) Multiple management modalities in esophageal cancer: combined modality management approaches. Oncologist 9:147–159

    CrossRef  Google Scholar 

  • Kramling HJ, Willich N, Cramer C, et al. (1997) Early results of IORT in the treatment of gastric cancer. Front Radiat Ther Oncol 31:157–160

    PubMed  CAS  Google Scholar 

  • Lagergren J, Bergstrom R, Lindgren A, Nyren O (2000) The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 85:340–346

    CrossRef  PubMed  CAS  Google Scholar 

  • Launois B, Delarue D, Campoin JP, Kerbaol M (1981) Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 153:690–692

    PubMed  CAS  Google Scholar 

  • Law S, Wong J (1997) The roles of multimodality treatment and lymphadenectomy in the management of esophageal cancer. Chin Med J (Engl). 110(11):819–825

    PubMed  CAS  Google Scholar 

  • Law S, Wong KH, Kwok KF, et al. (2004) Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 240:791–800

    CrossRef  PubMed  Google Scholar 

  • Lee JL, Park SI, Kim SB, et al. (2004) A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 15:947–954

    CrossRef  PubMed  CAS  Google Scholar 

  • Le Prise E, Etienne PL, Meunier B, et al. (1994) A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 73:1779–1784

    CrossRef  PubMed  Google Scholar 

  • Liao Z, Zhang Z, Jin J, et al. (2004) Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys 60:1484–1493

    CrossRef  PubMed  Google Scholar 

  • Lordick F, Siewert JR (2005) Recent advances in multimodal treatment for gastric cancer: a review. Gastric Cancer 8:78–85

    CrossRef  PubMed  Google Scholar 

  • Macdonald JS, Smalley SR, Benedetti J, et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730

    CrossRef  PubMed  CAS  Google Scholar 

  • Macdonald JS (2005) Role of post-operative chemoradiation in resected gastric cancer. J Surg Oncol 90:166–170

    CrossRef  PubMed  Google Scholar 

  • Maipang T, Vasinanukorn P, Petpichetchian C, et al. (1994) Induction chemotherapy in the treatment of patients with carcinoma of the esophagus. J Surg Oncol 56:191–197

    PubMed  CAS  Google Scholar 

  • Malthaner RA, Wong RKS, Rumble B, Zuraw L, Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care (2004) Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Medicine 2:35–52

    CrossRef  PubMed  Google Scholar 

  • Mari E, Floriani I, Tinazzi A, et al. (2000) Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. Ann Oncol 11:837–843

    CrossRef  PubMed  CAS  Google Scholar 

  • Medical Research Council Oesophageal Cancer Working Party (2002) Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomized controlled trial. Lancet 359:1727–1733

    CrossRef  Google Scholar 

  • Minsky BD, Pajak TF, Ginsberg RJ, et al. (2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial combined-modality therapy for esophageal cancer: highdose versus standard-dose radiation therapy. J Clin Oncol 20:1167–1174

    CrossRef  PubMed  CAS  Google Scholar 

  • Nygaard K, Hagen S, Hansen HS, et al. (1992) Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 16:1104–1109

    CrossRef  PubMed  CAS  Google Scholar 

  • Ogata T, Araki K, Matsuura K, et al (1995) A 10-year experience of intraoperative radiotherapy for gastric carcinoma and a new surgical method of creating a wider irradiation field for cases of total gastrectomy patients. Int J Radiat Oncol Biol Phys 32:341–347

    CrossRef  PubMed  CAS  Google Scholar 

  • Ott K, Sendler A, Becker K, et al. (2003) Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study. Gastric Cancer 6:159–167

    CrossRef  PubMed  CAS  Google Scholar 

  • Patel M, Ferry K, Franceschi D, et al. (2004) Esophageal carcinoma: current controversial topics. Cancer Invest 22:897–912

    CrossRef  PubMed  CAS  Google Scholar 

  • Pouliquen X, Levard H, Hay JM, et al. (1996) 5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus. A multicenter randomized trial. French Association for Surgical Research. Ann Surg 223:127–133

    CrossRef  PubMed  CAS  Google Scholar 

  • Rebecca WO, Richard MA (2003) Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev 1.

    Google Scholar 

  • Schlag PM (1992) Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft für Onkologie der Deutschen Gesellschaft für Chirurgie Study Group. Arch Surg. 127(12):1446–1450

    PubMed  CAS  Google Scholar 

  • Shi XH, Yao W, Liu T (1999) Late course accelerated fractionation in radiotherapy of esophageal carcinoma. Radiother Oncol 51:21–26

    CrossRef  PubMed  CAS  Google Scholar 

  • Siewert JR, Fink U, Sendler A, et al. (1997) Gastric cancer. Curr Probl Surg 34:835–939

    PubMed  CAS  Google Scholar 

  • Skoropad VY, Berdov BA, Mardynski YS, Titova LN (2000) A prospective, randomized trial of pre-operative and intraoperative radiotherapy versus surgery in respectable gastric cancer. Eur J Surg Oncol 26:773–779

    CrossRef  PubMed  CAS  Google Scholar 

  • Skoropad V, Berdov B, Zagrebin V (2002) Concentrated preoperative radiotherapy for resectable gastric cancer: 20-years follow-up of a randomized trial. J Surg Oncol 80:72–78

    CrossRef  PubMed  Google Scholar 

  • Smalley SR, Gunderson L, Tepper J, et al. (2002) Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys 52:283–293

    CrossRef  PubMed  Google Scholar 

  • Songun I, Keizer HJ, Hermans J, et al. (1999) Chemotherapy for operable gastric cancer: results of the Dutch randomized FAMTX trial. The Dutch Gastric Cancer Group (DGCG). Eur J Cancer 35:558–562

    CrossRef  PubMed  CAS  Google Scholar 

  • Stahl M, Stuschke M, Lehmann N, et al. (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317

    CrossRef  PubMed  Google Scholar 

  • Stein HJ, Brücher BL, Feith M, et al. (2000) Ösophaguskarzinom. In: Therapie gastrointestinaler Tumoren (German). Springer-Verlag, Berlin Heidelberg New York, pp 187–207

    Google Scholar 

  • Tachibana J, Yoshimura H, Kinugasa S, et al. (2003) Postoperative chemotherapy vs. chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial. Eur J Surg Oncol 29:580–587

    CrossRef  PubMed  CAS  Google Scholar 

  • Teniere P, Hay JM, Fingerhut A, Fagniez PL (1991) Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet 173:123–130

    PubMed  CAS  Google Scholar 

  • Tierney J, Arnott SJ, Duncan W, et al. (Oesophageal Cancer Collaborative Group) (2005) Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev 4.

    Google Scholar 

  • UICC (2002) TNM classification of malignant tumours, 6th edn. (Sobin LH, Wittekind Ch, eds). Wiley & Sons, New York

    Google Scholar 

  • Urba SG, Orringer MB, Turrisi A, et al. (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305–313

    PubMed  CAS  Google Scholar 

  • von Rahden BH, Stein HJ (2004) Therapy of advanced esophageal malignancy. Curr Opin Gastroentrol 20:391–396

    CrossRef  Google Scholar 

  • Walsh TN, Noonan N, Hollywood D, et al. (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462–467

    CrossRef  PubMed  CAS  Google Scholar 

  • Wang M, Gu XZ, Yin W, et al. (1989) Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma: report on 206 patients. Int J Radiat Oncol Biol Phys 16:325–327

    PubMed  CAS  Google Scholar 

  • Wang Y, Shi XH, He SQ, et al. (2002) Comparison between continuous accelerated hyperfractionated and latecourse accelerated hyperfractionated radiotherapy for esophageal carcinoma. In J Radiat Oncol Biol Phys 54:131–136

    CrossRef  Google Scholar 

  • Wong RKS, Malthaner RA, Zuraw L, Rumble RB, The Cancer Care Ontario Practice Guidelines Initiative Gastrointestinal Cancer Disease Site Group (2003) Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 55:930–942

    CrossRef  PubMed  Google Scholar 

  • Wilke H, Preusser P, Fink U, et al. (1989) Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin. J Clin Oncol 7:1318–1326

    PubMed  CAS  Google Scholar 

  • Xiao ZF, Yang ZY, Liang J, et al. (2003) Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 75:331–336

    CrossRef  PubMed  Google Scholar 

  • Zhang ZX, Gu XZ, Yin WB, et al. (1998) Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)-report on 370 patients. Int J Radiat Oncol Biol Phys 42:929–934

    CrossRef  PubMed  CAS  Google Scholar 

  • Zhao KL, Shi XH, Jiang GL, et al. (2005) Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study. Int J Radiat Oncol Biol Phys 62:1014–1020

    CrossRef  PubMed  CAS  Google Scholar 

  • Zieren HU, Muller JM, Jacobi CA, et al. (1995) Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomised study. World J Surg 19:444–449

    CrossRef  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22, 81675, Munich, Germany

    Frank Zimmermann MD

  2. Department of Surgery, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Str. 22, 81675, Munich, Germany

    Björn L. D. M. Brücher MD

Authors
  1. Frank Zimmermann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Björn L. D. M. Brücher MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford School of Medicine, 269 Campus Drive Center for Clinical Science and Research, Rm 1255, Stanford, CA, 94305-5152, USA

    J. Martin Brown PhD

  2. Department of Human Oncology, University of Wisconsin Hospital Medical School, 600 Highland Ave., K4 312-3684, Madison, WI, 53792, USA

    Minesh P. Mehta MD

  3. Department of Radiation Oncology, Klinikum rechts der Isar der Technischen Universität München, Ismaninger Strasse 22, 81675, München, Germany

    Carsten Nieder MD

Rights and permissions

Reprints and Permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Zimmermann, F., Brücher, B.L.D.M. (2006). Applications in Esophageal and Gastric Cancer. In: Brown, J.M., Mehta, M.P., Nieder, C. (eds) Multimodal Concepts for Integration of Cytotoxic Drugs. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-35662-2_14

Download citation

  • DOI: https://doi.org/10.1007/3-540-35662-2_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-25655-7

  • Online ISBN: 978-3-540-35662-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

search

Navigation